Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Ahmed; Salah U.
Address:
New City, NY
No. of patents:
12
Patents:












Patent Number Title Of Patent Date Issued
8580293 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof November 12, 2013
The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.
8288342 Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyp October 16, 2012
The present invention is directed to methods of treating vasomotor symptoms in castrated prostatic cancer patients in need of treatment, comprising administering about 15 mg or less of cyproterone acetate per day to the patients. The present invention is further directed to dosage fo
8247393 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof August 21, 2012
The present invention is directed to monophasic pharmaceutical compositions comprising a conjugated estrogen and a hydrophilic or lipophilic excipient. The present invention is also directed to kits and applicators comprising the pharmaceutical compositions. The invention is also dir
8226980 Orally disintegrating solid dosage forms comprising progestin and methods of making and using th July 24, 2012
The present invention is directed to non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising progestin and methods of making and using the dosage forms to treat conditions in females in need thereof.
8217024 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof July 10, 2012
The present invention is directed to monophasic pharmaceutical compositions comprising a conjugated estrogen and a hydrophilic or lipophilic excipient. The present invention is also directed to kits and applicators comprising the pharmaceutical compositions. The invention is also dir
8148560 Vaginal tablets comprising misoprostol and methods of making and using the same April 3, 2012
The present invention is directed to vaginal tablets comprising misoprostol and a pharmaceutically acceptable pH insensitive, hydrophilic cellulose material, wherein the vaginal tablets do not contain a hydrophobic release controlling agent, and wherein the misoprostol and the pharma
7910126 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for March 22, 2011
The present invention is directed to flexible, compressed intravaginal rings comprising a substantially homogeneous compressed mixture comprising a polymethacrylate, a plasticizer, and an active agent, and methods of making and using the same, and apparatus for making the same.
7867515 Orally disintegrating solid dosage forms comprising progestin and methods of making and use ther January 11, 2011
The present invention is directed to non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising progestin and methods of making and using the dosage forms to treat conditions in females in need thereof.
7838029 Mirtazapine solid dosage forms November 23, 2010
A non-effervescent, solid dosage form containing mirtazapine, which is used to form mirtazapine pharmaceutical tablets. The dosage form contains mirtazapine, a hydrophilic component, and at least one lubricant. In some embodiments, the dosage forms contain a salivating agent. Processes f
7811604 Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine a October 12, 2010
The present invention is directed to non-effervescent, orally disintegrating dosage forms comprising free base clozapine that are substantially free of acids, water-soluble polymers, taste-masking polymers, and coatings, and methods of making and using the same.
7390503 Ondansetron orally disintegrating tablets June 24, 2008
An ondansetron solid orally disintegrating dosage form for oral administration having at least one first water-dispersible component or water-insoluble cellulose derivative, a component having a --CHOH functional group, a disintegrating agent and at least one lubricant is provided. T
6221390 Combination pharmaceutical composition and associated methods April 24, 2001
A novel pharmaceutical combination is described, together with a method of making the same and a method of treating hypertensive patients using the same, wherein (1) the pharmaceutically active antihypertensive agent and citric acid and (2) the pharmaceutically active antikaliuretic agen










 
 
  Recently Added Patents
Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
Indicating transfer in an IMS network
Sink
Solid-state image capture device and image capture apparatus
Systems, methods and computer program products supporting provision of web services using IMS
Hypallergenic mosaic antigens and methods of making same
Stabilised prostaglandin composition
  Randomly Featured Patents
Tracking and erosion resistant composition
Spindle motor and magnetic disc device using thereof having radial and thrust bearings
Tracking usage of resources of a database system
Mechanical connector for structural members
Multicolor image forming method and apparatus
Development system
Method and apparatus for compressing digital data using non-adaptive predictive techniques
Guidance system that informs the vehicle operator that the vehicle is safely in the center of the correct road lane, airstrip, boat channel or path by means of passive elements imbedded or sub
Wind shield
Digital processing method and system for determination of optical flow